Summary

As part of Gilead’s enterprise AI strategy to accelerate the delivery of life-changing therapies, we are seeking an AI Data Science Lead to drive AI/ML innovation across Research (Gilead and Kite). This role will develop deep expertise across research domains including target discovery, translational research, biomarker development, early clinical research, and cell therapy. You will design and deliver AI-enabled solutions to accelerate scientific discovery and improve decision-making. You will partner with Product Owners, Solution Architects, and Delivery Leads to ensure scalable and compliant AI solutions. Reporting to the Director, Data & AI (Research), this role will lead end-to-end AI use cases and manage portfolio tracking and metrics across Research AI/ML initiatives.

Job description

Role Overview

As part of Gilead’s enterprise AI strategy to accelerate the delivery of life-changing therapies, we are seeking an AI Data Science Lead to drive AI/ML innovation across Research (Gilead and Kite). This role will develop deep expertise across research domains including target discovery, translational research, biomarker development, early clinical research, and cell therapy. You will design and deliver AI-enabled solutions to accelerate scientific discovery and improve decision-making. You will partner with Product Owners, Solution Architects, and Delivery Leads to ensure scalable and compliant AI solutions. Reporting to the Director, Data & AI (Research), this role will lead end-to-end AI use cases and manage portfolio tracking and metrics across Research AI/ML initiatives.

Key Responsibilities

Design and execute prompt engineering strategies and conduct experimentation to optimize AI model performance
Lead end-to-end AI/ML solutions across research use cases including pathological image processing, target identification and biomarker discovery
Translate scientific workflows into AI-ready problem definitions and technical specifications
Serve as Research SME in AI model design and solution architecture
Document current-state research workflows and design future-state AI-enabled processes
Apply AI and LLM-based approaches to unstructured scientific data
Validate AI solutions against scientific rigor and reproducibility standards
Support development of scalable AI solutions and provide post-implementation support
Contribute to the development of data solutions and provide post-implementation support including troubleshooting and root cause analysis
Manage portfolio-level tracking, executive dashboards, and metrics across all finance AI/ML use cases
Mentor junior data scientists

Skills and Experience

Bachelor’s or higher degree in Data Science, Computer Science, Bioinformatics, or related field with 6–10 years of experience
Strong experience applying AI/ML to life sciences research
Experience with prompt engineering, LLMs, and AI experimentation
Exposure to research domains such as discovery or translational sciences
Strong systems thinking and problem-solving skills
Experience working with scientific datasets (omics, imaging, or non-clinical)
Strong communication skills across scientific and technical teams
Ability to manage multiple AI initiatives and priorities

Requirements

Bachelor’s or higher degree in Data Science, Computer Science, Bioinformatics, or related field
6–10 years of experience
Strong experience applying AI/ML to life sciences research
Experience with prompt engineering, LLMs, and AI experimentation
Exposure to research domains such as discovery or translational sciences
Strong systems thinking and problem-solving skills
Experience working with scientific datasets (omics, imaging, or non-clinical)
Strong communication skills across scientific and technical teams
Ability to manage multiple AI initiatives and priorities

Benefits

Medical, Dental & Vision
Life Insurance
Paid Time Off
Annual Bonus
Stock-based Long-term Incentives

Company overview

Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.